ResearcherLoma Linda UniversityActive in the last 2 years
Nathan R. Wall
Matched on ORCID iD 0000-0002-3235-4386; OpenAlex author ID A5040623212. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 6)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 7
2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 2 papers
Papers 7
- Small non-coding RNAs and pancreatic ductal adenocarcinoma: Linking diagnosis, pathogenesis, drug resistance, and therapeutic potential. Last author DOI 10.1016/j.bbcan.2024.189153↗
- miRNA signatures underlie chemoresistance in the gemcitabine-resistant pancreatic ductal adenocarcinoma cell line MIA PaCa-2 GR. Last author DOI 10.3389/fgene.2024.1393353↗
- Pancreatic Cancer Health Disparity: Pharmacologic Anthropology. Co-author DOI 10.3390/cancers15205070↗
- Survivin Splice Variant 2β Enhances Pancreatic Ductal Adenocarcinoma Resistance to Gemcitabine. Last author DOI 10.2147/ott.s341720↗
- Curcumin Induces Pancreatic Adenocarcinoma Cell Death Via Reduction of the Inhibitors of Apoptosis. Last author DOI 10.1097/mpa.0000000000000411↗
- Curcumin Modulates Pancreatic Adenocarcinoma Cell-Derived Exosomal Function. Last author DOI 10.1371/journal.pone.0132845↗
- Enhancement of Gemcitabine sensitivity in pancreatic adenocarcinoma by novel exosome-mediated delivery of the Survivin-T34A mutant. Last author DOI 10.3402/jev.v3.23244↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ryan N. Fuller · 4 shared papers, 2022–2024 · strength 1.00
- Paper Small non-coding RNAs and pancreatic ductal adenocarcinoma: Linking diagnosis, pathogenesis, drug resistance, and thera… DOI 10.1016/j.bbcan.2024.189153↗
- Paper Pancreatic Cancer Health Disparity: Pharmacologic Anthropology. DOI 10.3390/cancers15205070↗
- Paper miRNA signatures underlie chemoresistance in the gemcitabine-resistant pancreatic ductal adenocarcinoma cell line MIA P… DOI 10.3389/fgene.2024.1393353↗
- Marino A. De León · 1 shared paper, 2023 · strength 0.26
- Charles Wang · 1 shared paper, 2024 · strength 0.26
- Tiantian Liu · 1 shared paper, 2024 · strength 0.26
- Carlos Joel Diaz Osterman · 3 shared papers, 2014–2016 · strength 0.17
- Paper Curcumin Induces Pancreatic Adenocarcinoma Cell Death Via Reduction of the Inhibitors of Apoptosis. DOI 10.1097/mpa.0000000000000411↗
- Paper Curcumin Modulates Pancreatic Adenocarcinoma Cell-Derived Exosomal Function. DOI 10.1371/journal.pone.0132845↗
- Paper Enhancement of Gemcitabine sensitivity in pancreatic adenocarcinoma by novel exosome-mediated delivery of the Survivin-… DOI 10.3402/jev.v3.23244↗
- Malyn May Asuncion Valenzuela · 1 shared paper, 2016 · strength 0.06
- Jonathan R. Aspe · 1 shared paper, 2014 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.